Scarica l'app Stockscreener
15.17
2.57%
0.38
Dopo l'orario di chiusura:
15.17
Precedente Chiudi:
$14.79
Aprire:
$14.79
Volume 24 ore:
774.00K
Relative Volume:
2.00
Capitalizzazione di mercato:
$627.01M
Reddito:
$320.17M
Utile/perdita netta:
$-36.74M
Rapporto P/E:
-17.13
EPS:
-0.8856
Flusso di cassa netto:
$-2.86M
1 W Prestazione:
+11.05%
1M Prestazione:
+15.89%
6M Prestazione:
+42.58%
1 anno Prestazione:
+77.22%
Intervallo 1D:
$14.79
$15.41
Intervallo di 1 settimana:
$13.87
$15.41
Portata 52W:
$8.36
$15.41
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
15.17 | 564.60M | 320.17M | -36.74M | -2.86M | -0.8856 |
ISRG
Intuitive Surgical Inc
|
375.41 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
170.21 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.21 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
40.47 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
215.19 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Lake Street | Buy |
| 2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Iniziato | Oppenheimer | Perform |
| 2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
| 2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Iniziato | Barclays | Equal Weight |
| 2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-04-08 | Ripresa | Piper Jaffray | Neutral |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Reiterato | Canaccord Genuity | Hold |
| 2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
| 2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax - Stock Titan
AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units - Stock Titan
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant - Stock Titan
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld - Stock Titan
AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding - Stock Titan
ANGO|AngioDynamics Inc|Price:13.825|Chg%:+0.235 - TradingKey
Form 4 AngioDynamics Inc For: 22 July By Investing.com - Investing.com Canada
AngioDynamics (ANGO) director receives 11,887-share stock award - Stock Titan
AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights - Stock Titan
ETFs Investing in AngioDynamics, Inc. Stocks - TradingView
AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations - Stock Titan
AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations - Stock Titan
AngioDynamics (ANGO) SVP covers tax obligations through share withholding - Stock Titan
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In - Seeking Alpha
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade) - Seeking Alpha
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - TradingView
AngioDynamics (NASDAQ: ANGO) details device portfolio and risk factors - Stock Titan
ANGIODYNAMICS INC FY 2026: Revenue $320.17M, EPS ($0.88) — 10-K Summary - TradingView
Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? E - GuruFocus
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
AngioDynamics, Inc. 2026 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-07-14 - Seeking Alpha
AngioDynamics Releases Q4 2026 Financial Results - AlphaStreet
Record 2026 sales as AngioDynamics (NASDAQ: ANGO) grows Med Tech 18% - Stock Titan
AngioDynamics: Fiscal Q4 Earnings Snapshot - KVUE
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Enterprise value to revenue forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to earnings forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Enterprise value to EBIT forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
AngioDynamics Inc. (ANGO) Rises 5.25%: Support and Resistance Levels in FocusInitial Balance - dars.gov.et
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
AngioDynamics Inc (ANGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AngioDynamics wins FDA okay to test NanoKnife in BPH patients - Stock Titan
AngioDynamics Inc (ANGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AngioDynamics Inc (ANGO) Institutional Confidence - TradingKey
AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026Slideshow - Seeking Alpha
ANGO News | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - AboutLawsuits.com
ANGO Technical Analysis & Stock Price Forecast - Intellectia AI
ANGO Stock Price, Quote & Chart | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):